Stevanato Group S.p.A. (STVN) Earnings Call Analysis
NYSE · Healthcare · Medical Instruments & Supplies
Next earnings call: 2026-08-04
(Q2 2026)
— full calendar
Earnings Reports
-
Stevanato Group (STVN) Q1 2026: GLP-1 Revenue Jumps to 22%, Cartridge Capacity Fully Booked
May 07, 2026
-
Stevanato Group (STVN) Q4 2025: High-Value Solutions Rise to 49% of Revenue, Anchoring Margin Expansion
March 04, 2026
-
Stevanato Group (STVN) Q3 2025: High-Value Solutions Jump to 49% of Revenue, Accelerating Strategic Mix Shift
November 06, 2025
-
Stevanato (STVN) Q2 2025: High-Value Solutions Hit 42% Mix, Margin Expansion Signals Biologics Tailwind
August 05, 2025
-
Stevanato (STVN) Q2 2025: High-Value Solutions Hit 42% of Revenue, Margin Expansion Signals Strategic Mix Shift
August 05, 2025
-
Stevanato (STVN) Q1 2025: High-Value Solutions Jump 25%, Accelerating Margin Expansion and U.S. Localization
July 07, 2025